The Test Strip Access Act of 2025 amends existing federal law to explicitly allow grants under the 21st Century Cures Act to be used for purchasing and distributing fentanyl and xylazine test strips as part of overdose prevention efforts. These test strips allow people who use drugs to detect the presence of fentanyl and xylazine—powerful and often deadly substances—in their drugs before consumption. The bill affects states and tribal nations that receive federal grants for substance use disorder prevention and treatment programs. By clarifying that test strips are an allowable use of these existing grant funds, the legislation aims to expand access to this harm-reduction tool without requiring new funding or establishing new timelines—it simply removes ambiguity about how current grant money can be spent to combat the ongoing opioid and overdose crisis.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.